Why is Brawn Biotech falling/rising?

As of 29-Aug, Brawn Biotech Ltd's stock price is rising, currently at 23.40, with an increase of 0.57, or 2.5%. The stock has shown strong performance recently, gaining 23.81% over the last five days and outperforming its sector by 1.87% today. Additionally, Brawn Biotech has generated a return of 13.04% over the past year, despite the broader market (BSE500) experiencing negative returns of -5.40%. However, the company faces challenges, including weak long-term fundamental strength indicated by an average Return on Equity (ROE) of 0% and declining net sales and operating profit over the past five years. The stock's risk is further highlighted by a negative EBITDA and poor ability to service its debt.
In the broader market context, Brawn Biotech's short-term return of +17.94% over the past week significantly outperforms the Sensex, which has declined by 1.84% in the same period. This stark contrast underscores the stock's resilience amid a generally unfavorable market environment. While the stock's recent gains are notable, the underlying financial weaknesses and risks associated with the company's performance may temper investor enthusiasm moving forward.